Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
04/01/2004 | CA2499269A1 Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds |
04/01/2004 | CA2498881A1 Process for differential diagnosis of alzheimer's dementia in patients exhibiting mild cognitive impairment |
04/01/2004 | CA2498325A1 Prophylactic and therapeutic hiv aptamers |
03/31/2004 | EP1403643A1 Lawsonia intracellularis cultivation, anti-lawsonia intracelluaris vaccines and diagnostic agents |
03/31/2004 | EP1403639A1 Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases |
03/31/2004 | EP1403370A1 Polynucleotide probe and primer for detecting beer-clouding lactic acid bacteria and method of detecting beer-clouding lactic acid bacteria |
03/31/2004 | EP1402261A1 Colon cancer antigen panel |
03/31/2004 | EP1402260A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
03/31/2004 | EP1402256A2 P-cadherin as a target for anti-cancer therapy |
03/31/2004 | EP1402070A2 Methods for the diagnosis of cancer based on the obcam and ntm genes |
03/31/2004 | EP1402066A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
03/31/2004 | EP1402058A2 Dgks as modifiers of the p53 pathway and methods of use |
03/31/2004 | EP1402054A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
03/31/2004 | EP1402053A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
03/31/2004 | EP1402036A2 Expression vectors encoding bacteriophage signal peptides |
03/31/2004 | EP1402035A2 G-protein coupled receptors and dna sequences thereof |
03/31/2004 | EP1402034A2 Identification of ses-1 and the uses of the same |
03/31/2004 | EP1402032A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis |
03/31/2004 | EP1402031A2 Atopy |
03/31/2004 | EP1402009A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof |
03/31/2004 | EP1402000A2 Structural and cytoskeleton-associated proteins |
03/31/2004 | EP1401999A2 B7 related protein-2 molecules and uses thereof |
03/31/2004 | EP1401872A1 Antigen targeting |
03/31/2004 | EP1401871A1 Immunological binding molecules inhibiting the syncytial fusion of trophoblast cells |
03/31/2004 | EP1401870A2 Antibodies against tumor necrosis factor delta (april) |
03/31/2004 | EP1401869A1 Molecules and methods for inhibiting shedding of kim-1 |
03/31/2004 | EP1401867A2 Mycobacterial antigens expressed under low oxygen tension |
03/31/2004 | EP1401865A2 Pathogenic and commensal vaccine antigens |
03/31/2004 | EP1401855A2 Novel fibroblast growth factor and nucleic acids encoding same |
03/31/2004 | EP1401498A1 Anti-ngf antibodies for the treatment of various disorders |
03/31/2004 | EP1401497A1 Methods for the modulation of il-13 |
03/31/2004 | EP1401496A1 Compositions and methods for treating hyperimmune response in the eye |
03/31/2004 | EP1401475A2 Prmts as modifiers of the p53 pathway and methods of use |
03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
03/31/2004 | EP1401470A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
03/31/2004 | EP1401467A1 Alpha-fetoprotein peptides and uses thereof |
03/31/2004 | EP1401286A1 Method of inhibiting fungal growth |
03/31/2004 | EP1401281A2 Toll/interleukin-1 receptor adaptor protein (tirap) |
03/31/2004 | EP1401269A2 Transgenic animal model of bone mass modulation |
03/31/2004 | EP1181318B1 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
03/31/2004 | EP1003863B1 Mammalian cytokine receptor-11 |
03/31/2004 | EP0866860B1 Novel tyrosine kinase receptors and ligands |
03/31/2004 | EP0852011B1 ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc |
03/31/2004 | EP0742833B1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies |
03/31/2004 | EP0735818B1 MACROPHAGE INFLAMMATORY PROTEINS MIP-3, MIP-4 AND MIP-1gamma |
03/31/2004 | EP0731806B1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
03/31/2004 | EP0710253B1 Antibodies specific for human prostate glandular kallikrein |
03/31/2004 | CN1486368A Methods for the production of multimeric proteins, and related compositions |
03/31/2004 | CN1486365A Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
03/31/2004 | CN1486194A Colorstrum-based composition |
03/31/2004 | CN1486192A Binding domain-immunoglobulin fusion proteins |
03/31/2004 | CN1486191A Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
03/31/2004 | CN1485432A Exhibiting method of preparing antibody by antigen utilizing bacteriophage exhibiting technique |
03/31/2004 | CN1485427A Polypeptide-human proteolytic enzyme 70 and polynucleotide encoding the polypeptide |
03/31/2004 | CN1485424A Polypeptide-human acetyl galactosyltransferase 45 and polynucleotide encoding the polypeptide |
03/31/2004 | CN1485423A Polypeptide-human galactosyltransferase 42 and polynucleotide encoding the polypeptide |
03/31/2004 | CN1485343A Production method of specific IgY for venereal disease and its combined preparation |
03/31/2004 | CN1485342A Method for preparing specific Immunoglobulin of cystvirus and adenovirus in respiratory tract |
03/31/2004 | CN1485340A Polypeptide-human transmembrane glycopeptide 25 and polynucleotide for encoding such polypeptide |
03/31/2004 | CN1485339A Polypeptide-human zinc finger protein 70 and polynucleotide for coding this polypeptide |
03/31/2004 | CN1485338A Polypeptide -Human vacuole carrier protein 13 and polynucleotide for encoding this polypeptide |
03/31/2004 | CN1485337A Polypeptide-human actin heavy chain 74 and polynucleotide for coding this polypeptide |
03/31/2004 | CN1485336A Polypeptide- human clathrin 82 and polynucleotide for coding such polypeptide |
03/31/2004 | CN1485335A Polypeptide-embryonic development protien 65 and polynucleotide for coding this polypeptide |
03/31/2004 | CN1485334A Polypeptide-human I complement receptor protein 222 and polynucleotide for coding such polypeptide |
03/31/2004 | CN1485333A Polypeptide-human X linked gene espression protein 14 and polynucleotide for encoding such polypeptide |
03/31/2004 | CN1485332A Polypeptide-human ª‰transducin 72 and polynucleotide for coding the same |
03/31/2004 | CN1144047C Method for testing or determining HCV core antigen and the agent for same |
03/30/2004 | US6713663 Flowering locus T (FT) and genetically modified plants having delayed flower development |
03/30/2004 | US6713619 Nucleic acid probe capable of detecting a single base difference between a nucleotide sequence present in a previously isolated human ras oncogene and a nucleotide sequence present in a corresponding human ras protooncogene |
03/30/2004 | US6713610 Human antibodies derived from immunized xenomice |
03/30/2004 | US6713609 Monoclonal antibodies to type I interferon receptor |
03/30/2004 | US6713606 Conjugates of soluble peptidic compounds with membrane-binding agents |
03/30/2004 | US6713453 Sustained release; drug delivery; tissue adhesive |
03/30/2004 | US6713451 Insulin-like growth factor agonist molecules |
03/30/2004 | US6713450 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
03/30/2004 | US6713302 Growth differentiation factor-6 |
03/30/2004 | US6713301 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
03/30/2004 | US6713283 Tyrosylprotein sulfotransferases |
03/30/2004 | US6713266 Immunoassay method for measuring a cyclosporine and its metabolites |
03/30/2004 | US6713061 Death domain containing receptors |
03/30/2004 | US6713059 Antibodies raised against immunogenic conjugates of gram-negative bacterial autoinducer molecules |
03/30/2004 | US6713058 Nervous system disorders; autoimmune diseases; anticancer agents |
03/30/2004 | US6713042 Ascorbic acid analogs for metalloradiopharmaceuticals |
03/30/2004 | CA2136103C Antibiotic cryptdin peptides and methods of their use |
03/30/2004 | CA2087347C Heterohybridomas producing human monoclonal antibodies to hiv-1 |
03/25/2004 | WO2004025416A2 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
03/25/2004 | WO2004025293A2 Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells |
03/25/2004 | WO2004025256A2 Viral deconstruction through capsid assembly in vitro |
03/25/2004 | WO2004024921A1 Human antihuman mcp-1 antibody and antibody fragment thereof |
03/25/2004 | WO2004024914A1 2’,5’-oligoadenylate phosphodiesterase |
03/25/2004 | WO2004024889A2 Production of bispecific molecules using polyethylene glycol linkers |
03/25/2004 | WO2004024874A2 Antibodies that recognize hyperproliferative cells and methods of making and using same |
03/25/2004 | WO2004024871A2 Antibodies and methods for generating genetically altered antibodies with high affinity |
03/25/2004 | WO2004024866A2 Protein purification |
03/25/2004 | WO2004024773A1 Methods for regulating cancer |
03/25/2004 | WO2004024772A1 Antibodies isolating and/or identifying neuronal stem cells and method for isolating and/ or identifying neuronal precursor cells |
03/25/2004 | WO2004024771A1 Human cd3-specific antibody with immunosuppressive properties |
03/25/2004 | WO2004024770A1 Polyclonal antibodies, preparation method thereof and use of same |
03/25/2004 | WO2004024769A2 Ostertagia vaccine |